MerckInc Overview
MerckInc Target Price
Analysts' 12-month price predictions for MRK.
Share Price
$84.18
Average Target Price
$98.00
16.4% upside
16.4% upside1 analysts in the last 4 months
High: $98 | Low: $98
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-07-10 | Morgan StanleyTerence Flynn | $98 | 16.4% upside |  |
| 2025-04-25 | BMO CapitalEvan Seigerman | $82 |  2.6% downside | |
| 2025-02-05 | Morgan StanleyTerence Flynn | $106 | 25.9% upside | |
| 2024-12-02 | BernsteinCourtney Breen | $110 | 30.7% upside | |
| 2024-11-15 | JefferiesAkash Tewari | $148 | 75.8% upside | |
| 2024-11-01 | BMO CapitalEvan David Seigerman | $136 | 61.6% upside | |
| 2024-10-09 | UBSTrung Huynh | $136 | 61.6% upside | |
| 2024-10-07 | BarclaysCarter Gould | $140 | 66.3% upside | |
| 2024-08-15 | JefferiesAkash Tewari | $147 | 74.6% upside | |
| 2024-07-31 | UBSColin Bristow | $142 | 68.7% upside | |
| 2024-07-31 | Bank of America SecuritiesGeoff Meacham | $145 | 72.2% upside | |
| 2024-06-12 | Wells FargoMohit Bansal | $140 | 66.3% upside | |
| 2024-05-30 | BMO CapitalEvan David Seigerman | $148 | 75.8% upside | |
| 2024-03-27 | Truist Financial | $142 | 68.7% upside | |
| 2024-03-27 | JefferiesAkash Tewari | $145 | 72.2% upside | |
| 2024-03-27 | Wells FargoMohit Bansal | $135 | 60.4% upside | |
| 2023-11-22 | Loop Capital MarketsEvan David Seigerman | $132 | 56.8% upside | |
| 2023-04-12 | OppenheimerJay Olson | $147 | 74.6% upside | |
| 2023-02-03 | Wells Fargo | $120 | 42.6% upside | |
| 2023-02-03 | Morgan Stanley | $99 | 17.6% upside | |
| 2023-01-03 | Wells Fargo | $125 | 48.5% upside | |
| 2022-12-19 | Cantor Fitzgerald | $135 | 60.4% upside | |
| 2022-11-18 | Credit Suisse | $120 | 42.6% upside | |
| 2022-09-30 | Leerink Partners | $110 | 30.7% upside | |
| 2022-09-12 | Leerink Partners | $109 | 29.5% upside | |
| 2022-07-29 | Barclays | $101 | 20% upside | |
| 2022-07-29 | Morgan Stanley | $92 | 9.3% upside | |
| 2022-07-29 | Leerink Partners | $105 | 24.7% upside | |
| 2022-07-18 | UBS | $98 | 16.4% upside | |
| 2022-07-13 | Atlantic Equities | $110 | 30.7% upside | |
| 2022-07-08 | Morgan Stanley | $88 | 4.5% upside | |
| 2022-04-29 | Morgan Stanley | $87 | 3.3% upside | |
| 2022-04-29 | Leerink Partners | $102 | 21.2% upside | |
| 2022-04-21 | Leerink Partners | $97 | 15.2% upside | |
| 2022-04-16 | BarclaysCarter Gould | $97 | 15.2% upside | |
| 2022-04-11 | Morgan StanleyTerence Flynn | $80 | 5% downside | |
| 2022-04-10 | BMO CapitalEvan David Seigerman | $87 | 3.3% upside | |
| 2021-12-17 | Goldman SachsChris Shibutani | $93 | 10.5% upside | |
| 2021-12-13 | UBSColin Bristow | $76 | 9.7% downside | |
| 2021-11-29 | CitigroupAndrew Baum | $85 | 1% upside | |
| 2021-11-01 | BarclaysCarter Gould | $94 | 11.7% upside | |
| 2021-11-01 | Argus ResearchDavid Toung | $110 | 30.7% upside | |
| 2021-10-29 | Bank of America SecuritiesGeoff Meacham | $86 | 2.2% upside | |
| 2021-10-29 | Wolfe ResearchTim Anderson | $94 | 11.7% upside | |
| 2021-07-29 | RBC CapitalDaniel Busby | $80 | 5% downside | |